Sign inTry free
Teva Pharmaceutical Industries (TEVA) logo

Teva Pharmaceutical Industries (TEVA) insider trading in the last 6 months

8 insiders sold $18.4M. No buys.

Filings: 12, in the last 6 months
Quality Score: 15, Excellent

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 12 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellMark Sabag$1.9MSee "Remarks"at $41.93 on Nov 5, filed Nov 6
SellDov Bergwerk$730KInterim Cheif Legal Officerat $41.72 on Nov 4, filed Nov 6
SellDov Bergwerk$365KInterim Cheif Legal Officerat $41.72 on Nov 4, filed Nov 6

From SEC Form 4s, the newest filed Nov 6, 2026 · Insiders have 2 business days to file a trade

9 more filings on TEVA in the last 6 months, for Pro members. See them free →

Pro members see every filing on TEVA with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Teva Pharmaceutical Industries

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about TEVA's insider trades

As of Nov 10, 2026: Teva Pharmaceutical Industries (TEVA) has 12 insider filings on record in the last 6 months, the newest filed Nov 6, 2026. Its Quality Score is 15 (Excellent). Scores as of 11:35 PM ET, 15 minutes behind.

Are TEVA insiders buying or selling?

8 insiders sold $18.4M across 12 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Mark Sabag, See "Remarks", sold $1.9M on Nov 5, 2026.

Who are TEVA's biggest insider sellers?

By the dollars of their sales in the last 6 months: Roberto Mignone (Director), 1 sale; Mark Sabag (See "Remarks"), 1 sale; Dov Bergwerk (Interim Cheif Legal Officer), 2 sales. 8 insiders sold in all.

When did a TEVA insider last buy?

No TEVA insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Mark Sabag on Nov 5, 2026.

Teva Pharmaceutical Industries's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Every insider trade, with its stock's score.

Real-time prices, every Form 4 on every stock with its Quality Score, sorting, filters, and optional alerts when the people you follow file.

See the last 30 days of insider trades

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Shares insiders bought or sold themselves, as filed on Form 4. Grants, option exercises, shares withheld for tax, and 10b5-1 plan sales are left out.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9, 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

May we record how this site is used and measure our ads? Privacy policy

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.